Silo Pharma, Inc. has announced the start of a pharmacokinetic and tolerability study for its novel, non-opioid extended-release pain therapeutic, SP-26, in collaboration with AmplifyBio. The study ...
PALO ALTO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (SCLX) (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results